SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hester shines on acquiring technology for production, commercialization of classical swine fever vaccine, sheep pox vaccine

08 Apr 2021 Evaluate

Hester Biosciences is currently trading at Rs. 2160.00, up by 146.95 points or 7.30% from its previous closing of Rs. 2013.05 on the BSE.

The scrip opened at Rs. 2027.05 and has touched a high and low of Rs. 2245.65 and Rs. 2027.05 respectively. So far 4679 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 2277.80 on 23-Mar-2021 and a 52 week low of Rs. 980.00 on 16-Apr-2020.

Last one week high and low of the scrip stood at Rs. 2245.65 and Rs. 1890.90 respectively. The current market cap of the company is Rs. 1844.54 crore.

The promoters holding in the company stood at 53.73%, while Institutions and Non-Institutions held 0.85% and 45.42% respectively.

Hester Biosciences has signed two agreements with ICAR-IVRI (Indian Council of Agricultural Research - Indian Veterinary Research Institute), for acquiring technologies for the production and commercialisation of the vaccines -- ‘Classical Swine Fever Vaccine’ and ‘Sheep Pox Vaccine’.

These vaccines are the first that have been developed within the country by using locally isolated strains, a step towards making India self-sufficient, Atmanirbhar, for the country’s requirement of Classical Swine Fever Vaccine and Sheep Pox Vaccine.

Hester Biosciences is engaged in the manufacturing of poultry vaccines.

Hester Biosciences Share Price

1649.65 11.45 (0.70%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×